PT92928A - Processo para a preparacao de mutantes da antitrombina iii humana e de composicoes farmaceuticas que os contem - Google Patents

Processo para a preparacao de mutantes da antitrombina iii humana e de composicoes farmaceuticas que os contem

Info

Publication number
PT92928A
PT92928A PT92928A PT9292890A PT92928A PT 92928 A PT92928 A PT 92928A PT 92928 A PT92928 A PT 92928A PT 9292890 A PT9292890 A PT 9292890A PT 92928 A PT92928 A PT 92928A
Authority
PT
Portugal
Prior art keywords
human
preparation
pharmaceutical compositions
compositions containing
iii mutants
Prior art date
Application number
PT92928A
Other languages
English (en)
Other versions
PT92928B (pt
Inventor
Gerd Zettlmeissl
Achim Becker
Hermann Erich Karges
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of PT92928A publication Critical patent/PT92928A/pt
Publication of PT92928B publication Critical patent/PT92928B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8128—Antithrombin III
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PT92928A 1989-01-24 1990-01-23 Processo para a preparacao de mutantes da antitrombina iii humana e de composicoes farmaceuticas que os contem PT92928B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3901917A DE3901917A1 (de) 1989-01-24 1989-01-24 Mutanten von humanem antithrombin iii

Publications (2)

Publication Number Publication Date
PT92928A true PT92928A (pt) 1990-07-31
PT92928B PT92928B (pt) 1995-12-29

Family

ID=6372631

Family Applications (1)

Application Number Title Priority Date Filing Date
PT92928A PT92928B (pt) 1989-01-24 1990-01-23 Processo para a preparacao de mutantes da antitrombina iii humana e de composicoes farmaceuticas que os contem

Country Status (13)

Country Link
US (2) US5618713A (pt)
EP (1) EP0384122B1 (pt)
JP (1) JP3226215B2 (pt)
KR (1) KR0171197B1 (pt)
AT (1) ATE184913T1 (pt)
AU (1) AU625667B2 (pt)
CA (1) CA2008390C (pt)
DE (2) DE3901917A1 (pt)
DK (1) DK0384122T3 (pt)
ES (1) ES2137918T3 (pt)
GR (1) GR3031991T3 (pt)
IE (1) IE900251L (pt)
PT (1) PT92928B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3479539B2 (ja) * 1992-04-10 2003-12-15 エーザイ株式会社 ヒトアンチトロンビンｉｉｉ変異体
EP1079791A4 (en) * 1998-05-12 2003-09-03 Susan C Bock HUMAN ANTITHROMBINS III AND RELATED METHODS
DE19839337A1 (de) * 1998-08-28 2000-03-02 Centeon Pharma Gmbh Antithrombin III-beta enthaltende Arzneimittelzubereitung
JP2002526418A (ja) 1998-10-08 2002-08-20 チルドレンズ ホスピタル 血管形成を阻害するための組成物と方法
AUPP971299A0 (en) * 1999-04-12 1999-05-06 South Eastern Sydney Area Health Service Procoagulant assay
ES2299425T3 (es) * 1999-05-13 2008-06-01 Gtc Biotherapeutics, Inc. Antitrombina iii producida geneticamente y formas mutantes de la misma.
JP4339962B2 (ja) * 1999-06-23 2009-10-07 武比古 小出 ヒトアンチトロンビン変異体
DE19932782A1 (de) * 1999-07-14 2001-01-18 Biotest Pharma Gmbh Verfahren zur chromatographischen Fraktionierung von Plasma oder Serum, so erhaltene Präparate und deren Verwendung
AU2003243381A1 (en) * 2002-05-31 2003-12-19 University Of Utah Research Foundation Variants of antithrombin iii
EP1725868A4 (en) * 2004-01-09 2008-02-06 Univ Utah Res Found METHODS OF USING ATIII VARIANTS WITH HIGH AFFINITY
WO2009013251A1 (en) * 2007-07-20 2009-01-29 Universite Paris-Sud Xi Use of mutated antithrombins for treating or preventing coagulation disorders
WO2010081878A1 (en) * 2009-01-16 2010-07-22 Universite Paris-Sud Xi Mutated antithrombins, a process for preparing the same and their use as drugs
JP2013510158A (ja) 2009-11-03 2013-03-21 グリフオルス・セラピユーテイクス・インコーポレーテツド α‐１プロテイナーゼインヒビターのための組成物、方法およびキット
WO2011066291A2 (en) 2009-11-24 2011-06-03 Talecris Biotherapeutics, Inc. Lyophilization methods, compositions, and kits

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2116183B (en) * 1982-03-03 1985-06-05 Genentech Inc Human antithrombin iii dna sequences therefore expression vehicles and cloning vectors containing such sequences and cell cultures transformed thereby a process for expressing human antithrombin iii and pharmaceutical compositions comprising it
US4746306A (en) * 1982-03-26 1988-05-24 General Motors Corporation Electrical connector lock with gauge pin
US4632981A (en) * 1982-07-30 1986-12-30 Genentech, Inc. Human antithrombin III
US4711848A (en) * 1984-03-14 1987-12-08 Zymogenetics, Inc. Site specific mutagenesis in alpha-1-antitrypsin
DE3624453A1 (de) * 1986-07-19 1988-01-28 Behringwerke Ag Verfahren zur herstellung von humanem antithrombin iii (atiii), dafuer geeignete vektoren und wirtszellen, so erhaltenes, biologisch aktives atiii und dieses enthaltende arzneimittel
GB8621118D0 (en) * 1986-09-01 1986-10-08 Whitbread & Co Plc Stabilised polypeptides
IE902276A1 (en) * 1989-06-26 1991-01-16 Akzo Nv Serpin variants

Also Published As

Publication number Publication date
JP3226215B2 (ja) 2001-11-05
EP0384122A3 (de) 1991-07-03
KR900011896A (ko) 1990-08-02
ATE184913T1 (de) 1999-10-15
KR0171197B1 (ko) 1999-02-01
DK0384122T3 (da) 2000-03-27
AU4863990A (en) 1990-09-13
GR3031991T3 (en) 2000-03-31
JPH02262598A (ja) 1990-10-25
DE3901917A1 (de) 1990-07-26
EP0384122A2 (de) 1990-08-29
US5700663A (en) 1997-12-23
EP0384122B1 (de) 1999-09-22
IE900251L (en) 1990-07-24
ES2137918T3 (es) 2000-01-01
PT92928B (pt) 1995-12-29
CA2008390C (en) 2002-03-19
US5618713A (en) 1997-04-08
AU625667B2 (en) 1992-07-16
CA2008390A1 (en) 1990-07-24
DE59010884D1 (de) 1999-10-28

Similar Documents

Publication Publication Date Title
PT93094A (pt) Processo para a preparacao de 1,3-oxatiolanos substituidos e de composicoes farmaceuticas que os contem
PT98369A (pt) Processo para a preparacao de azois substituidos e de composicoes farmaceuticas que os contem
PT96438A (pt) Processo para preparacao de anti-oxidante lipideo-selectivos e de composicoes farmaceuticas que os contem
PT99227A (pt) Processo para a preparacao de derivados da quinazolina e de composicoes farmaceuticas que os contem
PT97520A (pt) Processo para a preparacao de analogos de nucleosidos derivados de 1,3-oxatiolano e de composicoes farmaceuticas que os contem
BR8800660A (pt) (+)1r-trans-2,2-dimetil-3-(2,2-diclorovinil)-ciclopropano-carboxilato de 2,3,5,6-tetrafluorbenzilo,processo para sua preparacao,composicoes inseticidas,processos para o combate a insetos e para a preparacao de composicoes
PT88186A (pt) Processo para a preparacao de derivados 4'-fosfato de glucosidos da epipodofilotoxina e de composicoes farmaceuticas que os contem
PT99671A (pt) Processo para a preparacao de heparosanos-n,o-sulfatados e de composicoes farmaceuticas que os contem
PT94385A (pt) Processo para preparacao de derivados de n-fenilpirazol e de composicoes pesticidas que os contem
PT92928A (pt) Processo para a preparacao de mutantes da antitrombina iii humana e de composicoes farmaceuticas que os contem
PT89497A (pt) Processo para a preparacao de compostos piperidinilicos 1,4-dissubstituidos e de composicoes farmaceuticas que os contem
PT97114A (pt) Processo para a preparacao de derivados de hidantoina e de composicoes farmaceuticas que os contem
PT82414B (pt) Processo para a preparacao de agentes bactericidas a base de 5,6-difluoronaftiridinas e de 5,6,8-difluoroquinolinas e de composicoes farmaceuticas que os contem
PT82307B (pt) Processo para a preparacao de derivados da 4'-demetil-4-epipodofilotoxina e de composicoes farmaceuticas que os contem
PT93067A (pt) Processo para a preparacao de derivados de 2-hidroxiacidos alifaticos e de eteres de 1-benzil-3-hidroximetilindazol, e de composicoes farmaceuticas que os contem
BR8806217A (pt) Derivados de 2,2-difluorciclopropiletano,processo para sua preparacao,composicoes praguicidas e aplicacao
PT84358B (pt) Processo para a preparacao de naftotiazepinonas e de composicoes farmaceuticas que as contem
PT91870A (pt) Processo para apreparacao de novas quinoliloxazol-2-onas e de composicoes farmaceuticas que as contem
PT89145A (pt) Processo para a preparacao de derivados da manumicina e de composicoes farmaceuticas que os contem
PT84023B (pt) Processo para a preparacao de novos derivados da 1-benzeno-sulfonil-2-oxo-alcoxi-pirrolidina e de composicoes farmaceuticas que os contem
PT98816A (pt) Processo para a preparacao de tienodiazepinas e de composicoes farmaceuticas que as contem
PT87942A (pt) Processo para a preparacao de benzimidazois substituidos e de composicoes farmaceuticas que os contem
PT83419B (pt) Processo para a preparacao de 2-aminopurinas substituidas nas posicoes 6 e 9 e de composicoes farmaceuticas que contem estas purinas
PT87893A (pt) Processo para a preparacao de novos derivados glucosidicos da epipodofilotoxina 3', 4-diazoto-substituidos e de composicoes farmaceuticas que os contem
PT91787A (pt) Processo para a preparacao de tienopiranos substituidos e de composicoes farmaceuticas que os contem

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19950929

PC3A Transfer or assignment

Free format text: 980126 CENTEON PHARMA GMBH DE

PD3A Change of proprietorship

Owner name: AVENTIS BEHRING GMBH

Effective date: 20000316

MM3A Annulment or lapse

Effective date: 20060329